Leonetti & Associates’s AbbVie ABBV Stock Holding History

Leonetti & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-92,600	Closed	-$6.06M	–	42
2014 Q4	$6.06M	Sell	92,600 -2,600	-3%	-$164K	1.89%	16
2014 Q3	$5.5M	Buy	95,200 +50	+0.1%	+$2.78K	1.76%	20
2014 Q2	$5.37M	Buy	95,150 +700	+0.7%	+$36.7K	1.84%	17
2014 Q1	$4.86M	Buy	94,450 +2,000	+2%	+$101K	1.63%	21
2013 Q4	$4.88M	Buy	92,450 +3,550	+4%	+$174K	1.69%	17
2013 Q3	$3.98M	Sell	88,900 -2,000	-2%	-$88.7K	1.45%	20
2013 Q2	$3.76M	Buy	+90,900	New	+$3.98M	1.44%	21

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Leonetti & Associates's ABBV Position: Q1 2015 in Review

Leonetti & Associates sold out of AbbVie (ABBV) in Q1 2015, closing a stake of 92,600 shares — an estimated $6.06M sold.

Leonetti & Associates first reported a position in ABBV in Q2 2013 and held it in 7 quarters. The position peaked at $6.06M in Q4 2014. 1,601 funds tracked by Wall St. Rank hold ABBV as of Q1 2015.

Leonetti & Associates reported no remaining AbbVie position as of Q1 2015 after selling out during the quarter.
Leonetti & Associates sold 92,600 AbbVie shares in Q1 2015, an estimated $6.06M.
Leonetti & Associates first reported a position in AbbVie in Q2 2013 and held it in 7 quarters.
Leonetti & Associates's AbbVie position peaked at $6.06M in Q4 2014.
1,601 funds tracked by Wall St. Rank held AbbVie as of Q1 2015.

Based on Leonetti & Associates's 13F filing for Q1 2015, filed 15 May 2015.